2023-2024 will go down as a historic year in the Group’s history.
Alongside key achievements in our various therapeutic areas, it marked the celebration of our 70th anniversary.
We are proud to present the outcomes of our collective efforts in this report.
New opportunities in a constantly changing world
Servier operates in a world that is always evolving, and we take inspiration from the social and economic shifts to continually adapt and reinvent the way we work with a single goal in mind: bringing therapeutic innovations to patients with ever-increasing speed.
There are four specific challenges facing our industry this year that are driving our strategy, which we explore in greater detail. These relate to the influence of artificial intelligence (AI) on our innovation processes, the importance of considering patient adherence to treatment and how industry can address this issue, the interconnections between climate and health, and recruiting talent with highly specialized expertise.
Tangible achievements
Our Annual Integrated Report provides an overview of our company for a given financial year. And FY 2023-2024 featured important milestones in the realization of our Servier 2030 ambition.
We will therefore be taking a look back at the major progress we have made in oncology and in cardiometabolism, as well as at the factors that played a part in the overall success of our company during the year: new strategic partnerships, No. 3 ranking in the PatientView oncology survey, hosting the THRPTX Innovation Summit, and the role of our stakeholders.
This performance shapes the way we plan for the coming years to achieve our 2030 targets.